Effects of lamotrigine on PCP-evoked elevations in monoamine levels in the medial prefrontal cortex of freely moving rats

Journal of Psychopharmacology

Volumn 25, Issue 12, 2011, Pages 1703-1711

  Quarta, Davide ^a   Large, Charles H ^a  

^a GSK   (Italy)

Author keywords

Cortex; lamotrigine; microdialysis; monoamines; motor activity; PCP; rat

Indexed keywords

BRAIN MONOAMINE; DOPAMINE; LAMOTRIGINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NORADRENALIN; PHENCYCLIDINE; SEROTONIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; EVOKED RESPONSE; HYPERACTIVITY; IN VIVO STUDY; LOCOMOTION; MALE; MEDIAL PREFRONTAL CORTEX; MICRODIALYSIS; MONOAMINE RELEASE; NONHUMAN; NORADRENALIN BRAIN LEVEL; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOSIS; RAT; SCHIZOPHRENIA; SEROTONIN BRAIN LEVEL;

ANIMALS; BIOGENIC MONOAMINES; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MOTOR ACTIVITY; NOREPINEPHRINE; PHENCYCLIDINE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; TRIAZINES;

EID: 79959524970     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881110385598     Document Type: Article

References (65)

1. Abekawa T, Ito K, Koyama T. Different effects of a single and repeated administration of clozapine on phencyclidine-induced hyperlocomotion and glutamate releases in the rat medial prefrontal cortex at short- and long-term withdrawal from this antipsychotic. Naunyn Schmiedebergs Arch Pharmacol. 2007 ; 375: 261-271 (Pubitemid 46701627)
2. Adams B, Moghaddam B. Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci. 1998 ; 18: 5545-5554 (Pubitemid 28311969)
3. Ahmad S, Fowler LJ, Whitton PS. Effect of acute and chronic lamotrigine on basal and stimulated extracellular 5-hydroxytryptamine and dopamine in the hippocampus of the freely moving rat. Br J Pharmacol. 2004 ; 142: 136-142 (Pubitemid 38698202)
4. Anand A, Charney DS, Oren DA, et al. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Arch Gen Psychiatry. 2000 ; 57: 270-276 (Pubitemid 30140436)
5. Baldessarini RJ, Huston-Lyons D, Campbell A, Marsh E, Cohen BM. Do central antiadrenergic actions contribute to the atypical properties of clozapine?. Br J Psychiatry. 1992 ; 17 (Suppl). 12-16
6. Bourin M. The future of pharmacological models. Therapie. 1995 ; 50: 375-379
7. Brody SA, Geyer MA, Large CH. Lamotrigine prevents ketamine but not amphetamine-induced deficits in prepulse inhibition in mice. Psychopharmacology (Berl). 2003 ; 169: 240-246 (Pubitemid 37255516)
8. Casanovas JM, Hervas I, Artigas F. Postsynaptic 5-HT1A receptors control 5-HT release in the rat medial prefrontal cortex. Neuroreport. 1999 ; 10: 1441-1445 (Pubitemid 29354326)
9. Clark L, Cools R, Robbins TW. The neuropsychology of ventral prefrontal cortex: decision-making and reversal learning. Brain Cogn. 2004 ; 55: 41-53 (Pubitemid 38591429)
10. Clarke HF, Dalley JW, Crofts HS, Robbins TW, Roberts AC. Cognitive inflexibility after prefrontal serotonin depletion. Science. 2004 ; 304: 878-880 (Pubitemid 38620188)
11. Cunningham MO, Jones RS. The anticonvulsant, lamotrigine decreases spontaneous glutamate release but increases spontaneous GABA release in the rat entorhinal cortex in vitro. Neuropharmacology. 2000 ; 39: 2139-2146 (Pubitemid 30645637)
12. Deakin JF, Lees J, McKie S, Hallak JE, Williams SR, Dursun SM. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study. Arch Gen Psychiatry. 2008 ; 65: 154-164 (Pubitemid 351214314)
13. Di Forti M, Lappin JM, Murray RM. Risk factors for schizophrenia-all roads lead to dopamine. Eur Neuropsychopharmacol. 2007 ; 17 (Suppl 2). S101 - S107
14. Dursun SM, Deakin JF. Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic case-series outcome study. J Psychopharmacol. 2001 ; 15: 297-301 (Pubitemid 34024249)
15. Dursun SM, McIntosh D, Milliken H. Clozapine plus lamotrigine in treatment-resistant schizophrenia. Arch Gen Psychiatry. 1999 ; 56: 950 (Pubitemid 29480132)
16. French ED. Phencyclidine and the midbrain dopamine system: electrophysiology and behavior. Neurotoxicol Teratol. 1994 ; 16: 355-362 (Pubitemid 24269731)
17. Gimenez-Llort L, Ferre S, De Vera N, Martinez E. Motor depressant effects of systemically administered polyamines in mice: involvement of central NMDA receptors. Eur J Pharmacol. 1996 ; 318: 231-238 (Pubitemid 27046263)
18. Goff DC, Keefe R, Citrome L, et al. Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials. J Clin Psychopharmacol. 2007 ; 27: 582-589 (Pubitemid 351339444)
19. Goodwin GM, Bowden CL, Calabrese JR, et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry. 2004 ; 65: 432-441
20. Gozzi A, Large CH, Schwarz A, Bertani S, Crestan V, Bifone A. Differential effects of antipsychotic and glutamatergic agents on the phMRI response to phencyclidine. Neuropsychopharmacology. 2008 ; 33: 1690-1703 (Pubitemid 351684709)
21. Gray JA, Risch SC. When clozapine is not enough: augment with lamotrigine?. Current Psychiatry. 2009 ; 8: 41-46
22. Hainsworth AH, Spadoni F, Lavaroni F, Bernardi G, Stefani A. Effects of extracellular pH on the interaction of sipatrigine and lamotrigine with high-voltage-activated (HVA) calcium channels in dissociated neurones of rat cortex. Neuropharmacology. 2001 ; 40: 784-791 (Pubitemid 32436455)
23. Heidbreder CA, Lacroix L, Atkins AR, et al. Development and application of a sensitive high performance ion-exchange chromatography method for the simultaneous measurement of dopamine, 5-hydroxytryptamine and norepinephrine in microdialysates from the rat brain. J Neurosci Methods. 2001 ; 112: 135-144 (Pubitemid 33051115)
24. Hondo H, Yonezawa Y, Nakahara T, et al. Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study. Brain Res. 1994 ; 633: 337-342 (Pubitemid 24021280)
25. Howes OD, McDonald C, Cannon M, Arseneault L, Boydell J, Murray RM. Pathways to schizophrenia: the impact of environmental factors. Int J Neuropsychopharmacol. 2004 ; 7 (Suppl 1). S7 - S13
26. Hunt MJ, Garcia R, Large CH, Kasicki S. Modulation of high-frequency oscillations associated with NMDA receptor hypofunction in the rodent nucleus accumbens by lamotrigine. Prog Neuropsychopharmacol Biol Psychiatry. 2008 ; 32: 1312-1319
27. Idris NF, Repeto P, Neill JC, Large CH. Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and D-amphetamine in the rat. Psychopharmacology (Berl). 2005 ; 179: 336-348
28. Jackson ME, Homayoun H, Moghaddam B. NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. Proc Natl Acad Sci U S A. 2004 ; 101: 8467-8472 (Pubitemid 38736598)
29. Jentsch JD, Redmond DE, Elsworth JD, Taylor JR, Youngren KD, Roth RH. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science. 1997 ; 277: 953-955 (Pubitemid 27366680)
30. Ketter TA, Manji HK, Post RM. Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders. J Clin Psychopharmacol. 2003 ; 23: 484-495 (Pubitemid 37128677)
31. Konradi C, Heckers S. Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharmacol Ther. 2003 ; 97: 153-179 (Pubitemid 36138820)
32. Kremer I, Vass A, Gorelik I, et al. Placebo-controlled trial of lamotrigine added to conventional and atypical antipsychotics in schizophrenia. Biol Psychiatry. 2004 ; 56: 441-446 (Pubitemid 39195324)
33. Kubota T, Hirota K, Yoshida H, et al. Effects of sedatives on noradrenaline release from the medial prefrontal cortex in rats. Psychopharmacology (Berl). 1999 ; 146: 335-338 (Pubitemid 29480246)
34. Large CH. Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?. J Psychopharmacol. 2007 ; 21: 283-301 (Pubitemid 46934046)
35. Large CH, Di Daniel E, Li X, George MS. Neural network dysfunction in bipolar depression: clues from the efficacy of lamotrigine. Biochem Soc Trans. 2009 ; 37: 1080-1084
36. Large CH, Webster EL, Goff DC. The potential role of lamotrigine in schizophrenia. Psychopharmacology (Berl). 2005 ; 181: 415-436 (Pubitemid 41480891)
37. Leach MJ, Baxter MG, Critchley MA. Neurochemical and behavioral aspects of lamotrigine. Epilepsia. 1991 ; 32 (Suppl 2). S4 - S8
38. Lingamaneni R, Hemmings HC. Effects of anticonvulsants on veratridine- and KCl-evoked glutamate release from rat cortical synaptosomes. Neurosci Lett. 1999 ; 276: 127-130 (Pubitemid 29525506)
39. Liu G, Yarov-Yarovoy V, Nobbs M, Clare JJ, Scheuer T, Catterall WA. Differential interactions of lamotrigine and related drugs with transmembrane segment IVS6 of voltage-gated sodium channels. Neuropharmacology. 2003 ; 44: 413-422 (Pubitemid 36246496)
40. Lopez-Gil X, Artigas F, Adell A. Unraveling monoamine receptors involved in the action of typical and atypical antipsychotics on glutamatergic and serotonergic transmission in prefrontal cortex. Curr Pharm Des. 2010 ; 16: 502-515
41. Lopez-Gil X, Artigas F, Adell A. Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action. Int J Neuropsychopharmacol. 2009 ; 12: 487-499
42. Lorrain DS, Baccei CS, Bristow LJ, Anderson JJ, Varney MA. Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience. 2003 ; 117: 697-706 (Pubitemid 36263162)
43. Meldrum BS. The role of glutamate in epilepsy and other CNS disorders. Neurology. 1994 ; 44 (11 Suppl 8). S14 - S23
44. Messenheimer JA. Lamotrigine. Epilepsia. 1995 ; 36 (Suppl 2). S87 - S94
45. Moghaddam B, Adams B, Verma A, Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci. 1997 ; 17: 2921-2927 (Pubitemid 27155025)
46. Olney JW, Newcomer JW, Farber NB. NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res. 1999 ; 33: 523-533
47. Robbins TW. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl). 2002 ; 163: 362-380
48. Romero L, Artigas F. Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors. J Neurochem. 1997 ; 68: 2593-2603 (Pubitemid 27218184)
49. Rossler W, Salize HJ, van Os J, Riecher-Rossler A. Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol. 2005 ; 15: 399-409 (Pubitemid 40943544)
50. Sams-Dodd F. Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia. Behav Pharmacol. 1996 ; 7: 3-23 (Pubitemid 26051782)
51. Segovia G, Del Arco A, Mora F. Endogenous glutamate increases extracellular concentrations of dopamine, GABA, and taurine through NMDA and AMPA/kainate receptors in striatum of the freely moving rat: a microdialysis study. J Neurochem. 1997 ; 69: 1476-1483 (Pubitemid 27406948)
52. Smith DJ, Azzaro AJ, Zaldivar SB, Palmer S, Lee HS. Properties of the optical isomers and metabolites of ketamine on the high affinity transport and catabolism of monoamines. Neuropharmacology. 1981 ; 20: 391-396 (Pubitemid 11143399)
53. Smith RC, Meltzer HY, Arora RC, Davis JM. Effects of phencyclidine on [3H]catecholamine and [3H]serotonin uptake in synaptosomal preparations from rat brain. Biochem Pharmacol. 1977 ; 26: 1435-1439 (Pubitemid 8110344)
54. Southam E, Kirkby D, Higgins GA, Hagan RM. Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats. Eur J Pharmacol. 1998 ; 358: 19-24 (Pubitemid 28464464)
55. Southam E, Pereira R, Stratton SC, et al. Effect of lamotrigine on the activities of monoamine oxidases A and B in vitro and on monoamine disposition in vivo. Eur J Pharmacol. 2005 ; 519: 237-245 (Pubitemid 41278544)
56. Soyka M, Koch W, Moller HJ, Ruther T, Tatsch K. Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study. Eur Arch Psychiatry Clin Neurosci. 2005 ; 255: 308-312 (Pubitemid 41618802)
57. Stefani A, Spadoni F, Siniscalchi A, Bernardi G. Lamotrigine inhibits Ca2+ currents in cortical neurons: functional implications. Eur J Pharmacol. 1996 ; 307: 113-116 (Pubitemid 26226292)
58. Takahata R, Moghaddam B. Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine. Neuropsychopharmacology. 2003 ; 28: 1117-1124
59. Tiihonen J, Hallikainen T, Ryynanen OP, et al. Lamotrigine in treatment-resistant schizophrenia: a randomized placebo-controlled crossover trial. Biol Psychiatry. 2003 ; 54: 1241-1248 (Pubitemid 37464870)
60. Verma A, Moghaddam B. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J Neurosci. 1996 ; 16: 373-379 (Pubitemid 26010723)
61. Vinod KY, Subhash MN. Lamotrigine induced selective changes in 5-HT(1A) receptor mediated response in rat brain. Neurochem Int. 2002 ; 40: 315-319 (Pubitemid 34131605)
62. Waldmeier PC, Baumann PA, Wicki P, Feldtrauer JJ, Stierlin C, Schmutz M. Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters. Neurology. 1995 ; 45: 1907-1913 (Pubitemid 27122967)
63. Wang SJ, Huang CC, Hsu KS, Tsai JJ, Gean PW. Inhibition of N-type calcium currents by lamotrigine in rat amygdalar neurones. Neuroreport. 1996a ; 7: 3037-3040
64. Wang SJ, Huang CC, Hsu KS, Tsai JJ, Gean PW. Presynaptic inhibition of excitatory neurotransmission by lamotrigine in the rat amygdalar neurons. Synapse. 1996b ; 24: 248-255
65. Xie X, Hagan RM. Cellular and molecular actions of lamotrigine: Possible mechanisms of efficacy in bipolar disorder. Neuropsychobiology. 1998 ; 38: 119-130 (Pubitemid 28479447)